AlloClae Gains Users as GLP-1 Weight Loss Fuels Demand for Volume Restoration
Tiger Aesthetics says more than 2,000 patients have received the cadaver-derived injectable as clinics seek faster, larger-volume alternatives to fat grafting.
- AlloClae, a soft-tissue injectable derived from cadaver fat and marketed as "bottled fat grafting," has gained traction since May 2025, with Tiger Aesthetics reporting more than 2,000 patients treated for body contouring.
- Around 11% of Americans currently use weight-loss medications like Ozempic and Wegovy, according to a report published this month. Plastic surgeon Dr. Luis Macias noted patients on GLP-1s seek to "re-volumize" areas like breasts and buttocks after significant weight loss.
- The New York Department of Health rejected the manufacturer's license in October 2024 and again in May 2026, citing concerns about whether the injectable was "in compliance with FDA requirements" and questioning leadership competence.
- Sandra, a 43-year-old media lawyer based in Los Angeles, paid $13,000 for the procedure but developed fat necrosis two months later when the graft failed to vascularize, causing painful lumps and skin discoloration.
- Arthur Caplan, professor of bioethics at NYU's Grossman School of Medicine, called the commercialization of donated tissue an ethics problem, stating "it really is betraying altruism to make money.
13 Articles
13 Articles
Sandra*, a media lawyer and resident of Los Angeles, had been considering increasing the bust for years — since she was twenty— but it was always discouraged by the pain of the procedure, the long recovery period and the idea of...
Grasa de cadáveres para recuperar curvas: la controvertida tendencia que surge tras el auge de Ozempic
Por Leah Dolan, CNN Sandra*, una abogada especializada en medios de comunicación y residente en Los Ángeles, llevaba años considerando aumentarse el busto —desde que tenía veintitantos—, pero siempre la disuadían el dolor del procedimiento, el largo periodo de recuperación y la idea de llevar “una especie de bolsa de material extraño en el cuerpo”. Por eso cuando Sandra, que quiere proteger su identidad por motivos de privacidad, oyó hablar el v…
A new cosmetic procedure launched in the United States is stirring up controversy. More and more people are choosing to enlarge their breasts, buttocks or reshape other areas of their bodies with injections containing fat taken from deceased donors, writes CNN. Clinics promote it as a quick and minimally invasive alternative to implants, but critics call it "zombie filler."
AlloClae promises fast growth and no surgery, but raises ethical debates about its origin in donated bodies
Coverage Details
Bias Distribution
- 91% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
